Key result
Updated cardiorenal syndrome classification incorporates valvular heart disease and volume status alongside acute-chronic types.
Why the study?
Current cardiorenal syndrome consensus classifications rely solely on etiology and acute versus chronic disease course, prompting a proposed update incorporating additional clinical hallmarks.
An updated classification for cardiorenal syndrome incorporates valvular status and volume status to better direct therapeutic decisions.
Answers are grounded in this paper and cite their sources.
May guide volume and valvular assessment in cardiorenal syndrome; leaves open therapeutic utility pending validation studies.
Cardiorenal syndrome (CRS) is defined as progressive, combined cardiac and renal dysfunction. In this mini review, a historical note on CRS is presented, the pathomechanisms and clinical hallmarks of both chronic heart failure and chronic kidney disease are discussed, and an updated classification of CRS is proposed. The current consensus classification relies on the assumed etiology and the course of the disease, i.e., acute or chronic CRS. Five types are described: type-I CRS presenting as acute cardiac failure leading to acute renal failure; type-II CRS presenting as chronic cardiac failure leading to chronic renal failure; type-III CRS presenting as acute kidney injury aggravating heart failure; type-IV CRS presenting as chronic kidney failure aggravating heart failure; and type-V CRS presenting as concurrent, chronic cardiac and renal failure. For an updated classification, information on the presence or absence of valvular heart disease and on the presence of hyper- or hypovolemia is added. Thus, CRS is specified as "acute" (type-I, type-III or type-V CRS) or "chronic" (type-II, type-IV or type-V) CRS, as "valvular" or "nonvalvular" CRS, and as "hyper-" or "hypovolemia-associated" CRS if euvolemia is absent. To enable the use of this updated classification, validation studies are mandated.
No takes yet. Share an insight, caveat, or question.
Rainer U. Pliquett (2022) conducted a review in Cardiorenal Syndrome. An updated classification of cardiorenal syndrome is proposed, adding information on the presence of valvular heart disease and hyper- or hypovolemia to the traditional acute and chronic types.
Synapse has enriched 10 related papers. Consider them for comparative context: